|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 20/21/20 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/20/22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 01/01/2020 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01/01/2002 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
| Director/Board Member | 71 | 01/07/2019 | |
Kyle C. Kerbawy
CHM | Chairman | 79 | 01/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 34Cr | |
| +0.94% | +6.46% | -29.59% | -13.26% | 16TCr | |
| +1.48% | +2.07% | -6.03% | -6.92% | 10TCr | |
| -0.29% | +5.26% | -3.52% | +52.39% | 5.57TCr | |
| -2.09% | -6.13% | +51.65% | +53.01% | 5.29TCr | |
| +3.00% | +8.29% | -8.27% | -39.21% | 4.3TCr | |
| +2.91% | +8.15% | - | - | 3.29TCr | |
| +2.17% | -3.22% | -17.52% | -43.72% | 2.71TCr | |
| +1.24% | +6.98% | +60.21% | -3.90% | 2.48TCr | |
| +2.41% | +6.45% | -9.58% | +1.73% | 2.1TCr | |
| Average | +0.75% | +3.08% | +4.67% | +0.02% | 5.25TCr | |
| Weighted average by Cap. | +0.51% | +3.84% | -5.04% | -0.20% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 8.92Cr 7.82Cr 7.21Cr 6.75Cr 13Cr 841.64Cr 13Cr 87Cr 34Cr 415.96Cr 34Cr 33Cr 1.44TCr | 10Cr 8.84Cr 8.15Cr 7.63Cr 14Cr 950.82Cr 15Cr 98Cr 38Cr 469.92Cr 38Cr 37Cr 1.63TCr |
| Net income | -31.31L -27.46L -25.31L -23.69L -44.43L -30Cr -45.35L -3.04Cr -1.18Cr -15Cr -1.18Cr -1.15Cr -51Cr | 14.49L 12.7L 11.71L 10.96L 20.55L 14Cr 20.98L 1.41Cr 54.45L 6.75Cr 54.4L 53.21L 23Cr |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
